Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Henning Reis

Professor of Molecular Pathology

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt

Germany

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Internal Medicine

40%

Medical Imaging

40%

Cancer Biology

90%

Oncology

50%

Hepatology

40%

Bladder Cancer

40%

Pathology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Identifizierung und Validierung (diagnostischer) Biomarker beim Urachuskarzinom durch strukturierte proteomische Analysen

Open Date:

Close Date:

Grant: Close

NEOpredict-Lung – Neoadjuvant nivolumab combination treatment in early stage resectable non-small cell lung cancer patients: Defining optimal combinations and molecular and immunological determinants of response

Open Date:

Close Date:

Grant: Close

Proteasomal processing alterations as a novel mechanism of immune escape

Open Date:

Close Date:

Grant: Close

A prospective multiparametric biomarker approach towards personalizing lung cancer immuno-oncology

Open Date:

Close Date:

Grant: Close

Combined Androgen Receptor and Ataxia Telangiectasia and Rad3-related protein inhibition to enhance prostate-specific membrane antigen-directed radioligand therapy of prostate cancer.“

Open Date:

Close Date:

Henning Reis

Professor of Molecular Pathology

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Recent Grants

Articles30

Molekulares Tumorboard bei urologischen Tumoren: Hoffnung oder Enttäuschung?

International Society of Urological Pathology (ISUP) Multidisciplinary Consensus on Premalignant and Putative Precursor Lesions of Penile Cancer: Working Group 5 report on Terminology, Grading, and Molecular Testing Practices.

The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Glandular Lesions of the Urinary Bladder.

International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder.

Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601

Impact of Extended Versus Limited Lymph Node Dissection on Surgical Outcome, Recurrence Patterns and Survival After Radical Cystectomy

International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate.

The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms.

Multitracer comparison of gold standard PSMA-PET/CT with &lt;sup&gt;68&lt;/sup&gt;Ga-FAPI and &lt;sup&gt;18&lt;/sup&gt;F-FDG in high-risk prostate cancer: a proof-of-concept study.

Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients.

Histopathological, Molecular and Clinical Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder (LELC-B).

[German expert consensus on programmed cell death ligand 1 (PD-L1) testing in perioperative systemic therapy of muscle invasive bladder cancer].

Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer.

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder<sup>†</sup>.

Seltenere Tumoren und Tumortypen des ableitenden Harnsystems in der 5. Aufl. der WHO-Klassifikation 2022

Estimation of the incidence of urachal cancer: A systematic review and meta-analysis of registry-based studies.

Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device: A single center experience.

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.

Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in Germany.

Glandular Lesions of the Urinary Bladder: Diagnostic and Molecular Updates.

Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma

Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center

International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.

Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens.

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens.

International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility.

Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology.

[Current diagnostic and treatment strategies for urachal cancer].

CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE

Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder Cancer

Collaborators11

Fabian Finkelmeier

Peter J. Wild

Marcel Wiesweg

Kristof Cuppens

Florestan J. Koll

Jens Köllermann

Simon Bernatz

Alexandros Moraitis

Maximilian N. Kinzler

Stefan Zeuzem

Tibor Szarvas

How do I reach out?

Multitracer comparison of gold standard PSMA-PET/CT with <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG in high-risk prostate cancer: a proof-of-concept study.